Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • ExosomeDx
    Registered Vendor
    • Jul 2010
    • 1

    #1

    Scientist – Bioinformatics - Munich, Germany

    Exosome Diagnostics is an early stage company commercializing minimally invasive molecular diagnostics in blood and urine. The company's core technology is a proprietary diagnostic platform based on the discovery that circulating microvesicles called exosomes contain unique genetic markers.

    We are currently seeking an experienced Bioinformatics Scientist for our new German site, in the IZB in Martinsried outside Munich. This position will be responsible for providing key technical, statistical and intellectual input into the analysis of sequencing and array data of urine- and blood-based exosome RNA from patients with cancer, metabolic and other diseases.

    Candidates must be experienced in the field of next generation sequencing data analysis and preferably also microarray data analysis. We expect that you will have a strong background in molecular biology or similar, as well as bioinformatics or statistics.

    Key responsibilities include:
    • Analyze Next Gen Sequence data from exosome RNA derived from clinical samples.
    • Analyze microarray data from exosome RNA derived from clinical samples.
    • Deriving genetic signatures and biomarkers and evaluate their statistical validity.
    • Develop new algorithms and tools or modify existing ones to fit the needs for exosome RNA analysis.
    • Assist in the design of key experiments and companywide project plans to advance the development and understanding of the molecular biology of exosomes.
    • Provide assistance and training when required to aid the development of other team members.
    • Contribute data and analysis to intellectual property filings and peer reviewed publications.
    • Present thoughtful analysis and interact with the rest of the company’s scientific staff and key stake holders, including our collaborator network of world class hospitals and universities.

    We expect that you:
    • Have a several years experience from academia and/or industry.
    • Are experienced in the analysis and handling of NGS data.
    • Are proficient in the use of bioinformatics tools and are experienced in the programming skills needed for the job.
    • Have a scientific publication record and are up to date on current scientific literature in the field.
    • Can work independently and are deadline focused.
    • Are disciplined and organized and understand the importance of documenting your work.
    • Have a strong sense of integrity.
    • Enjoy a culture where strong work ethics are combined with good humor.
    • Are looking for an opportunity to contribute to significant research outside of large corporate structures.


    Exosome Diagnostics is an early stage company with an entrepreneurial culture that encourages constructive input from its employees.

    Interested candidates should submit a resume (Word or PDF format) to Human Resources: [email protected].

Latest Articles

Collapse

  • SEQadmin2
    16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
    by SEQadmin2




    NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
    Yesterday, 06:46 AM
  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
30 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:51 AM
0 responses
21 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
71 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
48 views
0 reactions
Last Post SEQadmin2  
Working...